News

Fusion Antibodies Ltd and Chiome Bioscience Inc collaboration in chicken antibody sequences humanization

Posted on

Fusion Antibodies have entered into collaboration with Japanese Biotechnology company Chiome Bioscience to humanize chicken antibodies. The project will use the capabilities of the Fusion Antibodies next generation Antibody Humanization CDRx platform to perform the avian antibody humanization. We are happy to announce that Fusion Antibodies expanded its footprint in the Asian market and has […]

Fusion Antibodies lead drug targeted at pancreatic cancer

Posted on

A novel pre-clinical antibody drug being developed by Fusion Antibodies (Belfast, NI) is being targeted at Pancreatic Cancer. Early in-vitro data has shown significant efficacy in Pancreatic Cancer cell lines and the Company is now seeking new investment funding to take this very exciting research into more advanced studies. The treatment of pancreatic cancer is […]

Fusion Antibodies to humanize Avipero’s Integrin antibody platform

Posted on

Fusion Antibodies Ltd has today announced a collaboration with the regenerative medicine company Avipero Ltd for humanization of their integrin antibody platform. The antibody engineering and humanization program partnered with Fusion Antibodies relates to the humanization of beta integrin targeting antibodies under development by Avipero for tissue repair and viral infections. The partnership of Avipero […]

Upcoming Events in 2014

Posted on

Fusion Antibodies will be attending the following events in 2014, we look forward to seeing you there! BioTrinity 2014European Biopartnering and Investment ConferenceLondon, May 12-14 2014 Biotech Outsourcing StrategiesCopenhagen, June 12th 2014 Biotech Outsourcing Strategies 2014Discovery/Early Development & Clinical Outsourcing TracksLondon Royal College of Physicians, 23rd September 2014 BIO-Europe 2014Frankfurt, 3–5 November Antibody Engineering & […]

Fusion Antibodies